

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal rod cell development (GO:0046548) | 9.87636887 |
| 2 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 8.93258042 |
| 3 | response to pheromone (GO:0019236) | 8.46040438 |
| 4 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 7.36060402 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 7.24586320 |
| 6 | sodium ion export (GO:0071436) | 6.54105190 |
| 7 | relaxation of smooth muscle (GO:0044557) | 6.52662684 |
| 8 | positive regulation of synapse maturation (GO:0090129) | 6.51550160 |
| 9 | potassium ion homeostasis (GO:0055075) | 6.42293912 |
| 10 | synaptic vesicle endocytosis (GO:0048488) | 5.77859140 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.39381929 |
| 12 | retinal cone cell development (GO:0046549) | 5.32174987 |
| 13 | striatum development (GO:0021756) | 5.22769328 |
| 14 | eye photoreceptor cell development (GO:0042462) | 5.18052121 |
| 15 | photoreceptor cell development (GO:0042461) | 5.17791725 |
| 16 | mating behavior (GO:0007617) | 5.14135081 |
| 17 | regulation of synapse maturation (GO:0090128) | 5.07673043 |
| 18 | innervation (GO:0060384) | 5.01896213 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.96262499 |
| 20 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.96260351 |
| 21 | rhodopsin mediated signaling pathway (GO:0016056) | 4.85609490 |
| 22 | urinary tract smooth muscle contraction (GO:0014848) | 4.76067896 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.74666787 |
| 24 | photoreceptor cell maintenance (GO:0045494) | 4.68816884 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.58353184 |
| 26 | protein localization to synapse (GO:0035418) | 4.51762591 |
| 27 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.37034159 |
| 28 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.37034159 |
| 29 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.34423207 |
| 30 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.30396417 |
| 31 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.30396417 |
| 32 | cellular sodium ion homeostasis (GO:0006883) | 4.29447732 |
| 33 | potassium ion export (GO:0071435) | 4.24444813 |
| 34 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.21097153 |
| 35 | cell communication by electrical coupling (GO:0010644) | 4.17120423 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13053556 |
| 37 | prepulse inhibition (GO:0060134) | 4.09129462 |
| 38 | calcium ion import (GO:0070509) | 4.07842597 |
| 39 | synaptic vesicle maturation (GO:0016188) | 4.06351770 |
| 40 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.98317951 |
| 41 | sensory perception of light stimulus (GO:0050953) | 3.96454593 |
| 42 | visual perception (GO:0007601) | 3.93597277 |
| 43 | peristalsis (GO:0030432) | 3.92045563 |
| 44 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.88076918 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.85939588 |
| 46 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.80049253 |
| 47 | establishment of synaptic vesicle localization (GO:0097480) | 3.79398118 |
| 48 | synaptic vesicle transport (GO:0048489) | 3.79398118 |
| 49 | detection of visible light (GO:0009584) | 3.71963966 |
| 50 | positive regulation of gastrulation (GO:2000543) | 3.69201058 |
| 51 | membrane hyperpolarization (GO:0060081) | 3.64677726 |
| 52 | detection of light stimulus (GO:0009583) | 3.59970007 |
| 53 | glycolytic process (GO:0006096) | 3.59580869 |
| 54 | long term synaptic depression (GO:0060292) | 3.56308749 |
| 55 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.55598754 |
| 56 | protein-chromophore linkage (GO:0018298) | 3.52039549 |
| 57 | axon cargo transport (GO:0008088) | 3.48044777 |
| 58 | response to histamine (GO:0034776) | 3.42340287 |
| 59 | atrial cardiac muscle cell action potential (GO:0086014) | 3.40904871 |
| 60 | regulation of bile acid biosynthetic process (GO:0070857) | 3.40130024 |
| 61 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37144305 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.35517438 |
| 63 | retina development in camera-type eye (GO:0060041) | 3.34773696 |
| 64 | synapse assembly (GO:0007416) | 3.33555414 |
| 65 | nonmotile primary cilium assembly (GO:0035058) | 3.31010034 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.29590083 |
| 67 | nitric oxide mediated signal transduction (GO:0007263) | 3.26596241 |
| 68 | response to host (GO:0075136) | 3.26492123 |
| 69 | response to host defenses (GO:0052200) | 3.26492123 |
| 70 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26492123 |
| 71 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.24139906 |
| 72 | anterograde axon cargo transport (GO:0008089) | 3.23471570 |
| 73 | glutamate receptor signaling pathway (GO:0007215) | 3.20335155 |
| 74 | behavioral response to cocaine (GO:0048148) | 3.19783644 |
| 75 | synaptic transmission, dopaminergic (GO:0001963) | 3.19207825 |
| 76 | dentate gyrus development (GO:0021542) | 3.19096159 |
| 77 | regulation of synaptic vesicle transport (GO:1902803) | 3.15807857 |
| 78 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.15471803 |
| 79 | iron coordination entity transport (GO:1901678) | 3.13981725 |
| 80 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.11863593 |
| 81 | positive regulation of TOR signaling (GO:0032008) | 3.08813297 |
| 82 | regulation of synapse structural plasticity (GO:0051823) | 3.05470427 |
| 83 | regulation of neurotransmitter uptake (GO:0051580) | 3.04275123 |
| 84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.03868229 |
| 85 | response to host immune response (GO:0052572) | 3.02329428 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02329428 |
| 87 | sialylation (GO:0097503) | 2.99925324 |
| 88 | behavioral response to ethanol (GO:0048149) | 2.98917112 |
| 89 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.97425898 |
| 90 | potassium ion import (GO:0010107) | 2.97303215 |
| 91 | retinal ganglion cell axon guidance (GO:0031290) | 2.96911059 |
| 92 | regulation of cardioblast proliferation (GO:0003264) | 2.95951377 |
| 93 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.95951377 |
| 94 | potassium ion transmembrane transport (GO:0071805) | 2.95529149 |
| 95 | cellular potassium ion transport (GO:0071804) | 2.95529149 |
| 96 | long-term synaptic potentiation (GO:0060291) | 2.93704918 |
| 97 | lactate metabolic process (GO:0006089) | 2.93549469 |
| 98 | pyrimidine dimer repair (GO:0006290) | 2.91210890 |
| 99 | detection of light stimulus involved in visual perception (GO:0050908) | 12.1725441 |
| 100 | detection of light stimulus involved in sensory perception (GO:0050962) | 12.1725441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.22699860 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.09823123 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.42478684 |
| 4 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.16980022 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.77379933 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.75723750 |
| 7 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.62375339 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47005922 |
| 9 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.40707868 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38606458 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35072872 |
| 12 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 2.34244638 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32499428 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31439158 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.31016585 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30347936 |
| 17 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.30171748 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16961979 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16777734 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12144291 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12097584 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03262303 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94900300 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94473516 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94235811 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94013816 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.91621641 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90384269 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90384269 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87192128 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84534242 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.82267207 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70317439 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68891536 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67863069 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64192349 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63988104 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63940461 |
| 39 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.61554144 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61240822 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57350156 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53277456 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52704306 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51959374 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46095937 |
| 46 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.45551516 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45495283 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43549206 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40304936 |
| 50 | AR_19668381_ChIP-Seq_PC3_Human | 1.35675224 |
| 51 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33391645 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31835462 |
| 53 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.29201538 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29093122 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28665313 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28121822 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27216920 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26780523 |
| 59 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25444340 |
| 60 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.24932929 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23763832 |
| 62 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.20978055 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20085026 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19912356 |
| 65 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18402080 |
| 66 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17242506 |
| 67 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.17185093 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17175578 |
| 69 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17175578 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17069080 |
| 71 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.12981648 |
| 72 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12182506 |
| 73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12016395 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11457298 |
| 75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09489732 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08882404 |
| 77 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.07896950 |
| 78 | CBP_21632823_ChIP-Seq_H3396_Human | 1.04140759 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04000514 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03553706 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03285334 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03185555 |
| 83 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01127406 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01084551 |
| 85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01084407 |
| 86 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99487530 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98541626 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96876173 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96263500 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96165762 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96038563 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95889045 |
| 93 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95740727 |
| 94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94700046 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94051691 |
| 96 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92461110 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92002086 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91993276 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91961100 |
| 100 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.90196040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 7.58923942 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 5.46835615 |
| 3 | MP0002090_abnormal_vision | 5.15675330 |
| 4 | MP0001984_abnormal_olfaction | 4.09589142 |
| 5 | MP0005253_abnormal_eye_physiology | 3.96057201 |
| 6 | MP0004782_abnormal_surfactant_physiolog | 3.59410821 |
| 7 | MP0004233_abnormal_muscle_weight | 3.26962326 |
| 8 | MP0003011_delayed_dark_adaptation | 3.12726093 |
| 9 | MP0001502_abnormal_circadian_rhythm | 3.03244995 |
| 10 | MP0005195_abnormal_posterior_eye | 2.96889757 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.85050905 |
| 12 | MP0005248_abnormal_Harderian_gland | 2.66224831 |
| 13 | MP0001346_abnormal_lacrimal_gland | 2.55577601 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.34399396 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.10606453 |
| 16 | MP0001324_abnormal_eye_pigmentation | 2.04214774 |
| 17 | MP0005394_taste/olfaction_phenotype | 2.03050857 |
| 18 | MP0005499_abnormal_olfactory_system | 2.03050857 |
| 19 | MP0008789_abnormal_olfactory_epithelium | 1.98420861 |
| 20 | MP0002229_neurodegeneration | 1.95624165 |
| 21 | MP0004215_abnormal_myocardial_fiber | 1.90536910 |
| 22 | MP0008775_abnormal_heart_ventricle | 1.89739436 |
| 23 | MP0002638_abnormal_pupillary_reflex | 1.89629357 |
| 24 | MP0003880_abnormal_central_pattern | 1.85711076 |
| 25 | MP0005670_abnormal_white_adipose | 1.85331323 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.78558545 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.76611012 |
| 28 | MP0005391_vision/eye_phenotype | 1.76213127 |
| 29 | MP0004036_abnormal_muscle_relaxation | 1.74284504 |
| 30 | MP0001486_abnormal_startle_reflex | 1.72763989 |
| 31 | MP0002752_abnormal_somatic_nervous | 1.65021812 |
| 32 | MP0010030_abnormal_orbit_morphology | 1.64449497 |
| 33 | MP0009046_muscle_twitch | 1.59374127 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.58770682 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.58114203 |
| 36 | MP0001188_hyperpigmentation | 1.57529715 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.53709567 |
| 38 | MP0002184_abnormal_innervation | 1.53509148 |
| 39 | MP0000631_abnormal_neuroendocrine_gland | 1.51520289 |
| 40 | MP0002272_abnormal_nervous_system | 1.47663248 |
| 41 | MP0002064_seizures | 1.45425459 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.44604029 |
| 43 | MP0005595_abnormal_vascular_smooth | 1.36828101 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.26947368 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.26117778 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.24107361 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.17213388 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.15395601 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.12289372 |
| 50 | MP0008569_lethality_at_weaning | 1.10556020 |
| 51 | MP0003879_abnormal_hair_cell | 1.08957929 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.08673284 |
| 53 | MP0009745_abnormal_behavioral_response | 1.06424166 |
| 54 | MP0002822_catalepsy | 1.04771399 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.04722441 |
| 56 | MP0004859_abnormal_synaptic_plasticity | 1.00116104 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 0.97439719 |
| 58 | MP0003137_abnormal_impulse_conducting | 0.92667868 |
| 59 | MP0003868_abnormal_feces_composition | 0.91895692 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 0.90381565 |
| 61 | MP0004043_abnormal_pH_regulation | 0.87273490 |
| 62 | MP0003634_abnormal_glial_cell | 0.80538915 |
| 63 | MP0004742_abnormal_vestibular_system | 0.79223817 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 0.78308149 |
| 65 | MP0002736_abnormal_nociception_after | 0.77825371 |
| 66 | MP0001529_abnormal_vocalization | 0.77492506 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.76896283 |
| 68 | MP0000955_abnormal_spinal_cord | 0.76210245 |
| 69 | MP0008260_abnormal_autophagy | 0.72911746 |
| 70 | MP0005620_abnormal_muscle_contractility | 0.71479578 |
| 71 | MP0002697_abnormal_eye_size | 0.66378778 |
| 72 | MP0004811_abnormal_neuron_physiology | 0.66032650 |
| 73 | MP0004085_abnormal_heartbeat | 0.65527590 |
| 74 | MP0000534_abnormal_ureter_morphology | 0.63211209 |
| 75 | MP0004924_abnormal_behavior | 0.60455794 |
| 76 | MP0005386_behavior/neurological_phenoty | 0.60455794 |
| 77 | MP0002557_abnormal_social/conspecific_i | 0.60293138 |
| 78 | MP0002069_abnormal_eating/drinking_beha | 0.58998261 |
| 79 | MP0004142_abnormal_muscle_tone | 0.57383847 |
| 80 | MP0003329_amyloid_beta_deposits | 0.57001212 |
| 81 | MP0002152_abnormal_brain_morphology | 0.56473854 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 0.55601120 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.55583141 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.54456729 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.53667796 |
| 86 | MP0000751_myopathy | 0.53386048 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.53375512 |
| 88 | MP0003633_abnormal_nervous_system | 0.50962604 |
| 89 | MP0004885_abnormal_endolymph | 0.49417402 |
| 90 | MP0008872_abnormal_physiological_respon | 0.49409013 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.49059934 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 0.48911532 |
| 93 | MP0002269_muscular_atrophy | 0.48821428 |
| 94 | MP0004270_analgesia | 0.48088470 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.47839079 |
| 96 | MP0009697_abnormal_copulation | 0.47808852 |
| 97 | MP0008004_abnormal_stomach_pH | 0.47397061 |
| 98 | MP0005646_abnormal_pituitary_gland | 0.46482674 |
| 99 | MP0000778_abnormal_nervous_system | 0.44684553 |
| 100 | MP0001970_abnormal_pain_threshold | 0.44276594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Central scotoma (HP:0000603) | 9.38562099 |
| 2 | Abnormality of macular pigmentation (HP:0008002) | 8.56755662 |
| 3 | Severe visual impairment (HP:0001141) | 8.33986711 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 7.38113256 |
| 5 | Scotoma (HP:0000575) | 6.56332966 |
| 6 | Septo-optic dysplasia (HP:0100842) | 6.42163076 |
| 7 | Decreased central vision (HP:0007663) | 5.97157550 |
| 8 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.71395758 |
| 9 | Albinism (HP:0001022) | 4.49557122 |
| 10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.46671574 |
| 11 | Hypoplasia of the fovea (HP:0007750) | 4.46671574 |
| 12 | Increased corneal curvature (HP:0100692) | 4.38116026 |
| 13 | Keratoconus (HP:0000563) | 4.38116026 |
| 14 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.79224111 |
| 15 | Abnormality of the fovea (HP:0000493) | 3.74760244 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.72675623 |
| 17 | Cholecystitis (HP:0001082) | 3.72675623 |
| 18 | Pendular nystagmus (HP:0012043) | 3.71842224 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.64375169 |
| 20 | Attenuation of retinal blood vessels (HP:0007843) | 3.55989617 |
| 21 | Febrile seizures (HP:0002373) | 3.51577125 |
| 22 | Absence seizures (HP:0002121) | 3.46778407 |
| 23 | Absent septum pellucidum (HP:0001331) | 3.30526733 |
| 24 | Optic nerve hypoplasia (HP:0000609) | 3.21173983 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 3.08307168 |
| 26 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.06465096 |
| 27 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.93359143 |
| 28 | Photophobia (HP:0000613) | 2.89631569 |
| 29 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.88612921 |
| 30 | Abnormality of the septum pellucidum (HP:0007375) | 2.85438692 |
| 31 | Chorioretinal atrophy (HP:0000533) | 2.79211262 |
| 32 | Severe Myopia (HP:0011003) | 2.77611447 |
| 33 | Dialeptic seizures (HP:0011146) | 2.74454641 |
| 34 | Pigmentary retinal degeneration (HP:0001146) | 2.71538228 |
| 35 | Dyschromatopsia (HP:0007641) | 2.66562900 |
| 36 | Type II diabetes mellitus (HP:0005978) | 2.59847647 |
| 37 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.55270130 |
| 38 | Prolonged QT interval (HP:0001657) | 2.55246016 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.53119181 |
| 40 | Cone-rod dystrophy (HP:0000548) | 2.51326650 |
| 41 | Abnormal pupillary function (HP:0007686) | 2.43646149 |
| 42 | Hemiparesis (HP:0001269) | 2.43553057 |
| 43 | Generalized hypopigmentation (HP:0007513) | 2.42728507 |
| 44 | Abnormality of the sella turcica (HP:0002679) | 2.40939445 |
| 45 | Retinitis pigmentosa (HP:0000510) | 2.36406988 |
| 46 | Constricted visual fields (HP:0001133) | 2.30240164 |
| 47 | Mutism (HP:0002300) | 2.25625163 |
| 48 | Growth hormone deficiency (HP:0000824) | 2.21073762 |
| 49 | Dysdiadochokinesis (HP:0002075) | 2.20619585 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16222673 |
| 51 | Abnormality of abdominal situs (HP:0011620) | 2.11518741 |
| 52 | Abdominal situs inversus (HP:0003363) | 2.11518741 |
| 53 | Gait imbalance (HP:0002141) | 2.10548988 |
| 54 | Choroideremia (HP:0001139) | 2.09682936 |
| 55 | Visual hallucinations (HP:0002367) | 2.02036678 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.01330741 |
| 57 | Neoplasm of the heart (HP:0100544) | 2.01218382 |
| 58 | Congenital stationary night blindness (HP:0007642) | 17.3692508 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 1.96887144 |
| 60 | Epileptiform EEG discharges (HP:0011182) | 1.87800973 |
| 61 | Macular degeneration (HP:0000608) | 1.83509648 |
| 62 | Nephrogenic diabetes insipidus (HP:0009806) | 1.83075810 |
| 63 | Astigmatism (HP:0000483) | 1.81532527 |
| 64 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77661751 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 1.76622869 |
| 66 | Poor coordination (HP:0002370) | 1.75675694 |
| 67 | Depression (HP:0000716) | 1.75614681 |
| 68 | Chorioretinal coloboma (HP:0000567) | 1.70157546 |
| 69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68508291 |
| 70 | Primary adrenal insufficiency (HP:0008207) | 1.67962534 |
| 71 | Ventricular fibrillation (HP:0001663) | 1.66964520 |
| 72 | Partial agenesis of the corpus callosum (HP:0001338) | 1.66793190 |
| 73 | Generalized tonic-clonic seizures (HP:0002069) | 1.66667145 |
| 74 | Abnormal EKG (HP:0003115) | 1.65110359 |
| 75 | True hermaphroditism (HP:0010459) | 1.63850695 |
| 76 | Posterior subcapsular cataract (HP:0007787) | 1.62580986 |
| 77 | Atrial fibrillation (HP:0005110) | 1.60816692 |
| 78 | Genetic anticipation (HP:0003743) | 1.59988067 |
| 79 | Cerebellar dysplasia (HP:0007033) | 1.58588328 |
| 80 | Unsteady gait (HP:0002317) | 1.56538988 |
| 81 | Optic disc pallor (HP:0000543) | 1.56521066 |
| 82 | Scanning speech (HP:0002168) | 1.46530620 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.46504886 |
| 84 | Dysmetric saccades (HP:0000641) | 1.46019008 |
| 85 | Primary atrial arrhythmia (HP:0001692) | 1.44293186 |
| 86 | Flat cornea (HP:0007720) | 1.39487037 |
| 87 | Fatigue (HP:0012378) | 1.39388262 |
| 88 | Syncope (HP:0001279) | 1.39156569 |
| 89 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.37702813 |
| 90 | Supraventricular tachycardia (HP:0004755) | 1.36617196 |
| 91 | Progressive visual loss (HP:0000529) | 1.35929112 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 1.35765623 |
| 93 | Exercise-induced myalgia (HP:0003738) | 1.34332493 |
| 94 | Maternal diabetes (HP:0009800) | 1.33877644 |
| 95 | Ankle clonus (HP:0011448) | 1.33554962 |
| 96 | Long toe (HP:0010511) | 1.33154429 |
| 97 | Genital tract atresia (HP:0001827) | 1.32810644 |
| 98 | Action tremor (HP:0002345) | 1.31023648 |
| 99 | Left ventricular hypertrophy (HP:0001712) | 1.30684744 |
| 100 | Supraventricular arrhythmia (HP:0005115) | 1.30613147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.41132394 |
| 2 | PAK6 | 3.95209179 |
| 3 | NEK1 | 3.77735944 |
| 4 | MAP3K4 | 3.19974932 |
| 5 | PRPF4B | 3.19538658 |
| 6 | TAOK2 | 3.15115632 |
| 7 | EPHA3 | 2.70331875 |
| 8 | DYRK1A | 2.51551240 |
| 9 | INSRR | 2.43585203 |
| 10 | NME1 | 2.36444698 |
| 11 | PHKG2 | 2.33621212 |
| 12 | PHKG1 | 2.33621212 |
| 13 | RIPK1 | 2.26584762 |
| 14 | MINK1 | 2.16112949 |
| 15 | MAP3K9 | 2.11537170 |
| 16 | STK38 | 1.99227726 |
| 17 | GRK1 | 1.92131298 |
| 18 | MARK1 | 1.86879859 |
| 19 | MAP3K7 | 1.69587068 |
| 20 | TNK2 | 1.68393361 |
| 21 | MAP3K13 | 1.66167849 |
| 22 | FES | 1.60526847 |
| 23 | STK38L | 1.56872088 |
| 24 | CDK3 | 1.50190166 |
| 25 | CAMK2D | 1.44354833 |
| 26 | FER | 1.32214923 |
| 27 | CLK1 | 1.32182510 |
| 28 | CDK8 | 1.31155302 |
| 29 | PINK1 | 1.22890780 |
| 30 | PRKAA1 | 1.14580316 |
| 31 | CAMK1D | 1.14418262 |
| 32 | IRAK2 | 1.08081010 |
| 33 | EPHA4 | 1.07554465 |
| 34 | TNIK | 0.97425201 |
| 35 | CDK14 | 0.97105388 |
| 36 | ROCK2 | 0.96570458 |
| 37 | SGK223 | 0.94945042 |
| 38 | SGK494 | 0.94945042 |
| 39 | CAMK1 | 0.86880423 |
| 40 | CAMK1G | 0.86382754 |
| 41 | BRD4 | 0.84190366 |
| 42 | CDK15 | 0.78194032 |
| 43 | PAK3 | 0.77092395 |
| 44 | CDK9 | 0.74652518 |
| 45 | CDK5 | 0.72687420 |
| 46 | CDK18 | 0.72640162 |
| 47 | PRKG2 | 0.72536105 |
| 48 | KSR2 | 0.71895508 |
| 49 | CDK11A | 0.71190669 |
| 50 | ERBB3 | 0.71151799 |
| 51 | MAP2K7 | 0.69619443 |
| 52 | PKN1 | 0.66849880 |
| 53 | PLK3 | 0.66500285 |
| 54 | MAPK10 | 0.66443113 |
| 55 | PRKG1 | 0.66423463 |
| 56 | PRKCZ | 0.65039506 |
| 57 | PRKCE | 0.62883198 |
| 58 | PRKCA | 0.62457314 |
| 59 | WNK3 | 0.60946815 |
| 60 | CAMK2A | 0.60613783 |
| 61 | PRKCG | 0.59906927 |
| 62 | MAP3K6 | 0.59666051 |
| 63 | PRKCB | 0.59099620 |
| 64 | PRKD2 | 0.58093020 |
| 65 | NEK2 | 0.58027496 |
| 66 | RPS6KA3 | 0.57911622 |
| 67 | CAMKK1 | 0.56818457 |
| 68 | TAOK3 | 0.56678628 |
| 69 | DYRK1B | 0.55599749 |
| 70 | KSR1 | 0.53641027 |
| 71 | MARK2 | 0.52404239 |
| 72 | GSK3B | 0.51582587 |
| 73 | ROCK1 | 0.50404586 |
| 74 | PRKACA | 0.48922200 |
| 75 | ARAF | 0.47467411 |
| 76 | RPS6KA5 | 0.45804715 |
| 77 | BCKDK | 0.43404378 |
| 78 | FGFR1 | 0.43337980 |
| 79 | AKT3 | 0.42440688 |
| 80 | MAPK8 | 0.42242586 |
| 81 | PRKACB | 0.42135720 |
| 82 | SIK2 | 0.41942353 |
| 83 | MAPK9 | 0.40799454 |
| 84 | SIK1 | 0.40507687 |
| 85 | PKN2 | 0.37947709 |
| 86 | PRKD3 | 0.37941950 |
| 87 | ERBB2 | 0.37919878 |
| 88 | BMX | 0.37679490 |
| 89 | AKT2 | 0.35332467 |
| 90 | PRKACG | 0.34976586 |
| 91 | MAPK14 | 0.34739322 |
| 92 | RPS6KB2 | 0.34122551 |
| 93 | HIPK2 | 0.33102371 |
| 94 | LMTK2 | 0.32961614 |
| 95 | CDC42BPA | 0.32574874 |
| 96 | CDK1 | 0.31970131 |
| 97 | CHEK2 | 0.31256782 |
| 98 | CAMK4 | 0.31159749 |
| 99 | MAP2K4 | 0.30882074 |
| 100 | AKT1 | 0.29103278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.57124311 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.30591540 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.95549820 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.85848345 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 3.36669457 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.15106563 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.71437047 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.60796734 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.50938615 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39220200 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.16244885 |
| 12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.13035627 |
| 13 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.12244347 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10975379 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 2.02355015 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.88785007 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.72415348 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72367483 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.71220956 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68055715 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67452887 |
| 22 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.61684551 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61318396 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59866539 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58676212 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56404945 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52352156 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44666398 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.36042952 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.30528541 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.29595642 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.27721737 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26258721 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24243639 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23620064 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22652050 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21091672 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.09781156 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.09159066 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07560527 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05856508 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03449882 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00030161 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86423643 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 0.84479693 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83894820 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76801767 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76072874 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75591954 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73623159 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73040963 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71093675 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64731752 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58465141 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57253478 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56421855 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.51297339 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.51156323 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49593730 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.48227370 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47940703 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45874979 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45626436 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.44384367 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43945605 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.43241017 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41120757 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39318364 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38388481 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36324606 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35591190 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35568158 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35056527 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34944948 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33204640 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33045476 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31484933 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29185292 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23140448 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.22786950 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21420728 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21194501 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20643929 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19963547 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19053913 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17597490 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16380588 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.15157975 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.14016884 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13396952 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.11965774 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.11487073 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.11467434 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10295572 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10274783 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.09945456 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09704879 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07628730 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.07081806 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.06732176 |

